- Conditions
- Impetigo, Secondarily Infected Traumatic Lesions
- Interventions
- TD1414 2% cream, Bactroban® (mupirocin) 2% cream
- Drug
- Lead sponsor
- LEO Pharma
- Industry
- Eligibility
- 2 Years and older
- Enrollment
- 773 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 1
- States / cities
- Anniston, Alabama
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Skin Infections, Bacterial
- Interventions
- Retpamulin Ointment, 1%, Linezolid
- Drug
- Lead sponsor
- Stiefel, a GSK Company
- Industry
- Eligibility
- 2 Months and older
- Enrollment
- 410 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 53
- States / cities
- Anniston, Alabama • Birmingham, Alabama • Bentonville, Arkansas + 46 more
- Conditions
- Secondarily Infected Traumatic Skin Lesions
- Interventions
- Mupirocin Calcium, Vehicle
- Drug
- Lead sponsor
- Padagis LLC
- Industry
- Eligibility
- 18 Months and older
- Enrollment
- 657 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- West Palm Beach, Florida
- Conditions
- Skin Infections, Bacterial
- Interventions
- Retapamulin Ointment, 1%, Placebo ointment
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 2 Months and older
- Enrollment
- 508 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 32
- States / cities
- Tucson, Arizona • Anaheim, California • Fresno, California + 27 more
- Conditions
- Secondarily Infected Traumatic Lesions (SITL), Impetigo
- Interventions
- 2% TD1414 Cream
- Drug
- Lead sponsor
- LEO Pharma
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 1
- States / cities
- College Station, Texas